IMDX Insight Molecular Diagnostics Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$4.36
Price · Aug 19, 2026
Fundamentals as of Aug 10, 2026

IMDX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$4.36
Market Cap
$125M
P/E (TTM)
-2.6
EPS (TTM)
$-1.65
Revenue (TTM)
$4M
Div Yield
ROE
330.8%
Debt/Equity
52W Range
$2 – $9

IMDX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $4M
6-point trend, +233.5%
2020-12-31 2025-12-31
EPS $-1.65
4-point trend, +87.5%
2022-12-31 2025-12-31
Free Cash Flow $-25M
4-point trend, -232.6%
2016-12-31 2025-12-31
Margins -1238.5%
3-point trend, +106.2%
2023-12-31 2025-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
IMDX
Peer Median
P/E (TTM)
4-point trend, -838.2%
-2.6
P/S (TTM)
3-point trend, +286.1%
30.8
28.5
P/B
4-point trend, -101.7%
-4.0
2.2
Price / FCF
4-point trend, +98.4%
-4.9

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
IMDX
Peer Median
Gross Margin
3-point trend, +106.2%
56.7%
51.3%
Operating Margin
4-point trend, -103.2%
-1260.8%
Net Profit Margin
4-point trend, -103.1%
-1238.5%
-1348.1%
ROA
4-point trend, -100.9%
-165.1%
-100.0%
ROE
4-point trend, +400.3%
330.8%
-154.7%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
IMDX
Peer Median
Current Ratio
4-point trend, -57.3%
1.3
2.9
Quick Ratio
4-point trend, -55.8%
1.1

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
IMDX
Peer Median
Revenue YoY
5-point trend, +84.5%
115.6%
Revenue CAGR 3Y
5-point trend, +84.5%
61.8%
Revenue CAGR 5Y
5-point trend, +84.5%
27.2%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
IMDX
Peer Median
EPS (Diluted)
4-point trend, +87.5%
$-1.65

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
IMDX
Peer Median

IMDX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 10 analysts
  • Strong Buy 2 20.0%
  • Buy 5 50.0%
  • Hold 3 30.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

3 analysts · 2026-08-18
Median target $9.00 +106.4%
Mean target $8.33 +91.1%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.29%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.23 $-0.25 0.02%
March 31, 2026 $-0.12 $-0.27 0.15%
Dec. 31, 2025 $-0.72 $-0.24 -0.48%
Sept. 30, 2025 $-0.34 $-0.21 -0.13%
June 30, 2025 $-0.30 $-0.23 -0.07%
March 31, 2025 $-0.26 $-0.24 -0.02%
Dec. 31, 2024 $-1.93 $-0.44 -1.5%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
IMDX $215M -4.5 115.6% -1238.5% 330.8% 56.7%
UNCY $128M -3.5 -29.0% -113.9%
EQ $95M -4.0 13.9% -133.1%
HURA -1.2
SPRB $120M -1.7 -51.3% -139.9%
INDP $6M -0.1 -2820.8%
OTLK $57M -0.6 -4416.2% 193.1% 4.0%
CBUS -0.6 -14.6% -3492.3% -223.0%
VTVT -70.4%
GNLX $166M -5.1 0.00% -401812.5% -181.4%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 17
Annual Income Statement data for IMDX
Metric Trend 20252024202320222021202020192018201720162015
Revenue 7-point trend, +4055000.00 $4M $2M $2M $958.0K $2M $1M · · · · $0
Cost of Revenue 6-point trend, -5.7% $2M $1M $1M $880.0K $697.0K $2M · · · · ·
Gross Profit 6-point trend, +459.6% $2M $740.0K $413.0K $-18.0K $1M $-639.0K · · · · ·
R&D Expense 11-point trend, +251.2% $16M $10M $9M $7M $5M $10M $7M $7M $7M $6M $5M
SG&A Expense 11-point trend, +175.0% $11M $10M $11M $22M $22M $17M $13M $7M $9M $4M $4M
Operating Expenses 11-point trend, +512.8% $53M $62M $26M $18M $55M $29M $22M $15M $19M $11M $9M
Operating Income 11-point trend, -486.4% $-51M $-61M $-25M $-18M $-54M $-30M $-22M $-15M $-19M $-11M $-9M
Interest Expense 2-point trend, -100.0% · · · · · · · · · $0 $18.0K
Other Non-op 11-point trend, +50450.0% $1M $462.0K $394.0K $-61.0K $-37.0K $27.0K $-3.0K $91.0K $-309.0K $0 $2.0K
Pretax Income 6-point trend, -170.5% · $-61M $-25M $-19M $-53M $-31M $-22M · · · ·
Income Tax 5-point trend, +100.0% $0 $0 $0 · $-9M $-1M · · · · ·
Net Income 11-point trend, -475.0% $-50M $-61M $-28M $-73M $-64M $-30M $-22M $-16M $-19M $-11M $-9M
EPS (Basic) 5-point trend, -129.2% $-1.65 $-4.66 $-3.75 $-13.25 $-0.72 · · · · · ·
EPS (Diluted) 4-point trend, +87.5% $-1.65 $-4.66 $-3.75 $-13.25 · · · · · · ·
Shares (Basic) 5-point trend, +34173.5% 30,476,000 13,071,000 7,651,000 5,540,000 88,920 · · · · · ·
Shares (Diluted) 4-point trend, +450.1% 30,476,000 13,071,000 7,651,000 5,540,000 · · · · · · ·
EBITDA 4-point trend, -339.2% $-49M $-59M $-25M · · · · · · $-11M ·
Balance Sheet 25
Annual Balance Sheet data for IMDX
Metric Trend 20252024202320222021202020192018201720162015
Cash & Equivalents 11-point trend, +44.9% $12M $9M $9M $20M $33M $7M $22M $8M $8M $10M $8M
Receivables 6-point trend, +455.7% $1M $2M $484.0K $2M $1M $203.0K · · · · ·
Inventory 2-point trend, +8.8% $446.0K $410.0K · · · · · · · · ·
Prepaid Expense 11-point trend, +266.0% $1M $821.0K $643.0K $977.0K $901.0K $1M $505.0K $180.0K $168.0K $285.0K $388.0K
Other Current Assets 6-point trend, +286.4% · · · · $85.0K $295.0K $36.0K $78.0K · $103.0K $22.0K
Current Assets 11-point trend, +40.1% $15M $12M $11M $26M $39M $9M $23M $9M $9M $13M $11M
PP&E (Net) 11-point trend, +1017.2% $6M $6M $5M $9M $7M $4M $4M $614.0K $822.0K $688.0K $576.0K
PP&E (Gross) 7-point trend, +766.8% · · · · $7M $2M $1M $2M $1M $1M $750.0K
Accum. Depreciation 11-point trend, +3834.5% $7M $8M $6M $4M $3M $1M $343.0K $948.0K $657.0K $319.0K $174.0K
Goodwill 2-point trend, +103.4% · · · · $19M $9M · · · · ·
Intangibles 9-point trend, -100.0% $0 $15M $57M $62M $62M $15M · · $746.0K $988.0K $1M
Other Non-current Assets 7-point trend, +537.6% $593.0K $691.0K $463.0K $371.0K $264.0K $356.0K $93.0K · · · ·
Total Assets 11-point trend, +102.3% $26M $35M $75M $100M $160M $55M $40M $10M $10M $14M $13M
Accounts Payable 11-point trend, +792.6% $3M $2M $953.0K $1M $2M $432.0K $469.0K $166.0K $175.0K $422.0K $285.0K
Accrued Liabilities 9-point trend, +657.2% $2M $2M $2M $2M $3M $3M · · $636.0K $549.0K $325.0K
Current Liabilities 11-point trend, +421.8% $12M $7M $7M $12M $14M $9M $4M $6M $4M $4M $2M
Capital Leases 4-point trend, +187000.00 · · · · · · · $187.0K $289.0K $310.0K $0
Total Liabilities 11-point trend, +2372.8% $57M $47M $49M $60M $94M $22M $9M $6M $6M $5M $2M
Long-term Debt · · · · · · · · $2M · ·
Common Stock 11-point trend, +957.9% $369M $338M $310M $295M $253M $157M $125M $75M $60M $46M $35M
Retained Earnings 11-point trend, -1560.6% $-401M $-351M $-290M $-261M $-188M $-124M $-94M $-71M $-55M $-35M $-24M
AOCI 8-point trend, +124.6% $86.0K $21.0K $49.0K $39.0K $37.0K · · · $-888.0K $-654.0K $-350.0K
Stockholders' Equity 11-point trend, -402.0% $-31M $-12M $20M $34M $65M $33M $31M $3M $4M $10M $10M
Liabilities + Equity 11-point trend, +102.3% $26M $35M $75M $100M $160M $55M $40M $10M $10M $14M $13M
Shares Outstanding 11-point trend, +13.0% 28,683,000 17,453,000 8,261,000 5,932,000 92,232,000 69,117,000 57,032,000 40,664,000 31,452,000 28,737,000 25,391,000
Cash Flow 15
Annual Cash Flow data for IMDX
Metric Trend 20252024202320222021202020192018201720162015
D&A 6-point trend, +601.9% $2M $2M $2M $2M $800.0K $313.0K · · · · ·
Stock-based Comp 9-point trend, +36.1% $2M $2M $3M $10M $7M $5M $3M $1M $2M · ·
Deferred Tax 4-point trend, +100.0% · · $0 $0 $-9M $-1M · · · · ·
Amort. of Intangibles 10-point trend, -97.1% $7.0K $88.0K $88.0K $4M $3M $81.0K · $121.0K $242.0K $242.0K $242.0K
Other Non-cash 2-point trend, -35.5% $24M $37M · · · · · · · · ·
Operating Cash Flow 11-point trend, -424.6% $-22M $-21M $-23M $-46M $-36M $-26M $-20M $-12M $-13M $-8M $-4M
CapEx 11-point trend, +537.0% $3M $516.0K $281.0K $4M $2M $1M $918.0K $31.0K $91.0K $106.0K $500.0K
Investing Cash Flow 11-point trend, -1111.1% $-3M $-512.0K $-932.0K $-4M $-14M $-12M $-12M $-31.0K $843.0K $-181.0K $315.0K
Debt Issued · · · · · $1M · · · · ·
Stock Issued 10-point trend, +150.2% $29M $26M $14M $33M $65M $18M $49M $10M · $0 $12M
Net Stock Activity 4-point trend, +29143000.00 $29M $26M $14M · · · · · · $0 ·
Financing Cash Flow 11-point trend, +140.9% $28M $20M $12M $36M $78M $23M $48M $12M $10M $10M $12M
Net Change in Cash 11-point trend, -66.6% $3M $-796.0K $-12M $-14M $28M $-15M $16M $434.0K $-3M $2M $8M
Taxes Paid Flat — no change across 2 periods $0 $0 · · · · · · · · ·
Free Cash Flow 4-point trend, -232.6% $-25M $-21M $-24M · · · · · · $-8M ·
Profitability 8
Annual Profitability data for IMDX
Metric Trend 20252024202320222021202020192018201720162015
Gross Margin 3-point trend, +106.2% 56.7% 39.3% 27.5% · · · · · · · ·
Operating Margin 4-point trend, -103.2% -1260.8% -3245.1% -1672.4% · · · · · · 39785.7% ·
Net Margin 4-point trend, -103.1% -1238.5% -3225.0% -1848.4% · · · · · · 39885.7% ·
Pretax Margin 2-point trend, -95.0% · -3225.0% -1653.7% · · · · · · · ·
EBITDA Margin 4-point trend, -103.0% -1206.6% -3162.0% -1672.4% · · · · · · 39785.7% ·
ROA 4-point trend, -100.9% -165.1% -110.3% -31.8% · · · · · · -82.2% ·
ROE 4-point trend, +400.3% 330.8% 4733.8% -98.2% · · · · · · -110.1% ·
ROIC · 497.3% · · · · · · · · ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for IMDX
Metric Trend 20252024202320222021202020192018201720162015
Current Ratio 4-point trend, -57.3% 1.3 1.6 1.5 · · · · · · 3.0 ·
Quick Ratio 4-point trend, -55.8% 1.1 1.4 1.4 · · · · · · 2.4 ·
Efficiency 3
Annual Efficiency data for IMDX
Metric Trend 20252024202320222021202020192018201720162015
Asset Turnover 4-point trend, +6447.6% 0.1 0.0 0.0 · · · · · · -0.0 ·
Inventory Turnover 2-point trend, -20.4% 4.1 5.1 · · · · · · · · ·
Receivables Turnover 3-point trend, +6.0% 3.0 1.8 2.8 · · · · · · · ·
Per Share 5
Annual Per Share data for IMDX
Metric Trend 20252024202320222021202020192018201720162015
Book Value / Share 4-point trend, -419.6% $-1.10 $-0.70 $2.48 · · · · · · $0.34 ·
Revenue / Share 3-point trend, -32.2% $0.13 $0.14 $0.20 · · · · · · · ·
Cash Flow / Share 3-point trend, +76.1% $-0.73 $-1.58 $-3.05 · · · · · · · ·
Cash / Share 4-point trend, +14.1% $0.40 $0.49 $1.14 · · · · · · $0.35 ·
EPS (TTM) 4-point trend, +87.5% $-1.65 $-4.66 $-3.75 $-13.25 · · · · · · ·
Growth Rates 3
Annual Growth Rates data for IMDX
Metric Trend 20252024202320222021202020192018201720162015
Revenue YoY 5-point trend, +43.1% 115.6% 25.1% 56.9% -56.4% 80.8% · · · · · ·
Revenue CAGR 3Y 3-point trend, +743.7% 61.8% -5.1% 7.3% · · · · · · · ·
Revenue CAGR 5Y 27.2% · · · · · · · · · ·
Valuation (TTM) 10
Annual Valuation (TTM) data for IMDX
Metric Trend 20252024202320222021202020192018201720162015
Revenue TTM 7-point trend, +4055000.00 $4M $2M $2M $958.0K $2M $1M · · · · $0
Net Income TTM 11-point trend, -475.0% $-50M $-61M $-28M $-73M $-64M $-30M $-22M $-16M $-19M $-11M $-9M
Market Cap 4-point trend, -94.7% $215M $42M $21M · · · · · · $4.05B ·
P/E 4-point trend, -838.2% -4.5 -0.5 -0.7 -0.5 · · · · · · ·
P/S 3-point trend, +286.1% 53.1 22.1 13.7 · · · · · · · ·
P/B 4-point trend, -101.7% -6.8 -3.4 1.0 · · · · · · 410.9 ·
P / Tangible Book · · · · · 355.7 · · · · ·
P / Cash Flow 4-point trend, +98.2% -9.7 -2.0 -0.9 · · · · · · -538.7 ·
P / FCF 4-point trend, +98.4% -8.5 -2.0 -0.9 · · · · · · -531.2 ·
Earnings Yield 4-point trend, +89.3% -22.0% -195.8% -150.0% -206.4% · · · · · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $4M$2M$2M$958.0K$2M
Gross Margin % 56.7%39.3%27.5%
Operating Margin % -1260.8%-3245.1%-1672.4%
Net Income $-50M$-61M$-28M$-73M$-64M
Diluted EPS $-1.65$-4.66$-3.75$-13.25
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 1.31.61.5
Quick Ratio 1.11.41.4
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-25M$-21M$-24M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 44 filers · $106.4M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
15 (+1 vs prior Q) 13 (+6 vs prior Q) 8 (-1 vs prior Q) 7 (0 vs prior Q) +157K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
BROADWOOD CAPITAL INC $74,840,816 12,684,884 70.32% Shares
AWM Investment Company, Inc. $16,736,483 2,836,692 15.73% Shares
VANGUARD CAPITAL MANAGEMENT LLC $4,341,497 735,847 4.08% Shares
PURA VIDA INVESTMENTS, LLC $2,860,585 484,845 2.69% Shares
Family Office Research LLC $2,176,207 368,849 2.04% Shares
GEODE CAPITAL MANAGEMENT, LLC $1,225,570 207,516 1.15% Shares
JANE STREET GROUP, LLC $930,324 157,682 0.87% Shares
VANGUARD FIDUCIARY TRUST CO $734,998 124,576 0.69% Shares
STATE STREET CORP $543,532 92,124 0.51% Shares
MILLENNIUM MANAGEMENT LLC $486,744 82,499 0.46% Shares
NORTHERN TRUST CORP $289,631 49,090 0.27% Shares
OSAIC HOLDINGS, INC. $230,901 39,136 0.22% Shares
MORGAN STANLEY $200,323 33,953 0.19% Shares
Jefferies Financial Group Inc. $106,790 18,100 0.10% Shares
MARSHALL WACE, LLP $97,922 16,597 0.09% Shares
ExodusPoint Capital Management, LP $82,771 14,029 0.08% Shares
AXQ CAPITAL, LP $79,101 13,407 0.07% Shares
Flatrock Wealth Partners LLC $76,960 13,044 0.07% Shares
TWO SIGMA INVESTMENTS, LP $65,496 11,101 0.06% Shares
XTX Topco Ltd $63,384 10,743 0.06% Shares
Private Advisor Group, LLC $61,454 10,416 0.06% Shares
VANGUARD GROUP INC $43,313 5,775 0.04% Shares
BNP PARIBAS FINANCIAL MARKETS $34,226 5,801 0.03% Shares
Vanguard Global Advisers, LLC $34,073 5,775 0.03% Shares
EverSource Wealth Advisors, LLC $29,500 5,000 0.03% Shares
BlackRock, Inc. $17,122 2,902 0.02% Shares
Tower Research Capital LLC (TRC) $15,877 2,691 0.01% Shares
Steward Partners Investment Advisory, LLC $11,564 1,960 0.01% Shares
UBS Group AG $3,564 604 0.00% Shares
ORG Partners LLC $2,625 350 0.00% Shares
SBI Securities Co., Ltd. $1,092 185 0.00% Shares
FNY Investment Advisers, LLC $1,077 182,561 0.00% Shares
ROYAL BANK OF CANADA $1,000 251 0.00% Shares
JPMORGAN CHASE & CO $835 154 0.00% Shares
JONES FINANCIAL COMPANIES LLLP $340 63 0.00% Shares
Caitong International Asset Management Co., Ltd $266 45 0.00% Shares
Piscataqua Savings Bank $147 25 0.00% Shares
ALBION FINANCIAL GROUP /UT $42 7 0.00% Shares
WELLS FARGO & COMPANY/MN $41 7 0.00% Shares
Cassaday & Co Wealth Management LLC $36 6 0.00% Shares
MERCER GLOBAL ADVISORS INC /ADV $30 5 0.00% Shares
Global Retirement Partners, LLC $6 1 0.00% Shares
Farther Finance Advisors, LLC $6 1 0.00% Shares
Motiv8 Investments LLC $0 10 0.00% Shares

Company insiders 18 insiders · 8 officers · 10 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Ronald Asbury Andrews Chief Executive Officer July 1, 2019 A 0 0 $0
William Annett President and CEO March 14, 2019 A 0 0 $0
Mitchell S Levine Chief Financial Officer Sept. 12, 2019 P 10,000 0 0 $0
Albert P Parker Chief Operating Officer March 14, 2019 A 0 0 $0
Tony T Kalajian SVP-Chief Accounting Officer Sept. 13, 2019 P 10,000 0 0 $0
Lyndal K. Hesterberg Chief Scientific Officer March 14, 2019 A 0 0 $0
Kristine C. Mechem VP of Marketing June 7, 2018 A 0 0 $0
Karen B. Chapman Vice President of Research Feb. 16, 2016 A 0 0 $0
Andrew J. Last Director July 1, 2026 F 58,752 0 0 $0
Andrew Arno Director July 1, 2026 F 156,785 0 0 $0
Lou Silverman Director July 1, 2026 F 55,807 0 0 $0
Aditya P. Mohanty Director July 17, 2019 A 0 0 $0
Cavan M. Redmond Director July 17, 2019 A 0 0 $0
Alfred D Kingsley Director July 17, 2019 A 0 0 $0
Don M Bailey Director June 15, 2017 A 0 0 $0
Michael D West Director Feb. 16, 2016 A 0 0 $0
BIOTIME INC 10% owner July 5, 2019 S 12,424,244 0 0 $0
John Peter Gutfreund June 30, 2023 J 0 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 5 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher ×15 filings April 27, 2026 39.70% Amendment Passive investment SEC
Lineage Cell Therapeutics, Inc. 1 S.S. OR ×4 filings Jan. 8, 2021 Initial filing SEC
BioTime, Inc. 1 S.S. OR ×5 filings July 5, 2019 Initial filing SEC
BioTime, Inc. S.S. OR Aug. 29, 2016 Initial filing Board campaign SEC
BioTime, Inc. Dec. 31, 2015 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 3 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.01% 43,256 SH Aug. 8, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 248,059 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 475,405 SH Aug. 8, 2026 Daily